<
Notification of revising non -prescription drug instructions containing Valicate hydrochloride
stake betting appMy stake betting appRelease time: 2012-05-26 & nbsp & nbsp & nbsp Source:

Each province、Autonomous Region、Food and Drug Administration (Drug Supervision Administration):

 

To ensure the safety of children's medication,According to the provisions of [Children's Medicine] in the description in the one -square preparation manual of the Valicate hydrochloride,Now amending the instructions of non -prescribed drugs (OTC),and notify the relevant matters as follows:

 

1、Revisory content of the instructions of non -prescribed drugs containing Valicate hydrochloride


(1) For ammonia golden sensitive particles that are only used for children、Pediatrichine amine mampamine granules、Pediatric compound aminopolyine tablet tablets,Delete [Precautions] "Children under 1 year old should use under guidance",Add data in the [taboo] item.,Newborn and babies stake online sports bettingstake sports betting appunder 1 year old disable this product。”

 

(2) For children,It can also be used for adults to adults to Nasamine Naamin capsules,"Children under 5 years of age should be used under the guidance of doctors" as "children under 5 years old are not recommended to use",Add data in the [taboo] item.,Newborn and babies stake online sports bettingstake sports betting appunder 1 year old disable this product。”

 

(3) For compound aminamine tablets for adults,​​Delete [Precautions] The content of "Children must be used under adult monitoring" content。

 

2、Please notify the drug production enterprises in the administrative area to revise the instructions and labels as soon as possible,and inform the revised content in time、Drug business enterprises and other units。Related drug manufacturers should also actively track the safety of the clinical application of such drugs,Collect adverse reactions in accordance with regulations stake betting appstake sports betting appand report it in time。

 


                                  National Food and Drug Administration
                                   May 7, 2012